Sutro Biopharma, Inc. (STRO) stock
STRONasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
$9.59−0.67 (-6.53%)
Close on Nov 12, 2026Market cap $159.01MP/E –Yield –
Sutro Biopharma market cap
Market capitalization is the share price multiplied by the number of shares outstanding.
Sutro Biopharma's market cap was $170.07M on Nov 11, 2026, against $78.24M a year earlier. Over the last 5 years it ranged from $54.04M to $688.36M, with a median of $264.31M.
Market Cap at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $170.07M | +72.7% |
| 2025 | Dec 31, 2025 | $98.46M | -35.1% |
| 2024 | Dec 31, 2024 | $151.61M | -42.0% |
| 2023 | Dec 29, 2023 | $261.26M | -40.8% |
| 2022 | Dec 30, 2022 | $441.42M | -35.9% |
| 2021 | Dec 31, 2021 | $688.36M | -16.8% |
| 2020 | Dec 31, 2020 | $827.00M | +225.6% |
| 2019 | Dec 31, 2019 | $253.99M | +5704.7% |
| 2018 | Dec 31, 2018 | $4.38M | – |
See a number that looks wrong?